1. Home
  2. UVV vs BBNX Comparison

UVV vs BBNX Comparison

Compare UVV & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$52.29

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Beta Bionics Inc. Common Stock

BBNX

Beta Bionics Inc. Common Stock

HOLD

Current Price

$29.39

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
BBNX
Founded
1886
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
UVV
BBNX
Price
$52.29
$29.39
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$28.09
AVG Volume (30 Days)
176.9K
618.5K
Earning Date
11-05-2025
10-28-2025
Dividend Yield
6.28%
N/A
EPS Growth
N/A
N/A
EPS
4.44
N/A
Revenue
$2,987,411,000.00
$88,570,000.00
Revenue This Year
$3.21
$52.13
Revenue Next Year
$1.02
$36.16
P/E Ratio
$11.77
N/A
Revenue Growth
3.01
67.01
52 Week Low
$49.40
$8.89
52 Week High
$67.33
$32.71

Technical Indicators

Market Signals
Indicator
UVV
BBNX
Relative Strength Index (RSI) 45.49 55.31
Support Level $52.30 $27.87
Resistance Level $53.25 $31.51
Average True Range (ATR) 0.81 2.09
MACD -0.00 -0.22
Stochastic Oscillator 23.91 47.23

Price Performance

Historical Comparison
UVV
BBNX

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: